Financial Statement

Fiscal Year Ends	:	December
( in million Rupiah except Par Value, Per Share Data and Ratios )
Statement Date	:	2026-06-30
Balance Sheet
Cash & Cash Equivalents	:	683,703
Curr. Assets	:	1,676,398
Fixed Assets	:	654,587
Total Assets	:	2,330,986
Curr. Liabilities	:	308,089
Long Term Debt	:	213,625
Minority Interest	:	0
Total Liabilities	:	521,714
Paid-Up Capital	:	402
Total Equity	:	1,809,271
Income Statement
Total Sales	:	986,358
Gross Profit	:	275,569
Operating Profit	:	33,195
Net Income	:	20,148
Cash Flow Statement
Cash From Operating Act	:	166,799
Cash From Investing Act	:	-15,340
Cash From Financing Act	:	-17,244
Per Share Data (in IDR)
EPS	:	50.10
Book Value	:	4,499.18
Financial Ratios
Der	:	0.29
Roa	:	0.01
Roe	:	0.01
Npm	:	0.02
Opm	:	0.03
Growth Year to Year
Sales (%)	:	-8.71%
Net Income (%)	:	-140.45%
Total Assets (%) (%)	:	28.97%
Total Liabilities (%)	:	-1.84%

1	Corgan Expands Aviation Practice in Asia Pacific with Ben Dawson Hire

2	The 2026 Xiong'an Forum of China Computational Power Conference was held

3	QurCan Therapeutics Enters Strategic Research and Collaboration Agreement with Lilly

4	Gradiant Wins New Water Contracts for Major US Semiconductor Fabs in New York, Virginia, Idaho, and Utah

5	Medisca Launches Global Peptide Division

Corgan Expands Aviation Practice in Asia Pacific with Ben Dawson Hire